These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 7521091
1. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Oesterling JE, Kaplan SA, Epstein HB, Defalco AJ, Reddy PK, Chancellor MB. Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091 [Abstract] [Full Text] [Related]
2. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study. Guazzoni G, Montorsi F, Coulange C, Milroy E, Pansadoro V, Rubben H, Sarramon JP, Williams G. Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092 [Abstract] [Full Text] [Related]
3. Long-term experience utilizing a new balloon expandable prostatic endoprosthesis: the Titan stent. North American Titan Stent Study Group. Kaplan SA, Chiou RK, Morton WJ, Katz PG. Urology; 1995 Feb; 45(2):234-40. PubMed ID: 7855972 [Abstract] [Full Text] [Related]
4. The UroLume endoprosthesis: a summary of the European and North American experience. Oesterling JE. Prog Clin Biol Res; 1994 Feb; 386():561-75. PubMed ID: 7528427 [Abstract] [Full Text] [Related]
5. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103 [Abstract] [Full Text] [Related]
6. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Cowles RS, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, Zabbo A. Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818 [Abstract] [Full Text] [Related]
7. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Kaplan SA, Te AE. Urology; 1995 Apr; 45(4):566-72. PubMed ID: 7536365 [Abstract] [Full Text] [Related]
8. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. Chancellor MB, Gajewski J, Ackman CF, Appell RA, Bennett J, Binard J, Boone TB, Chetner MP, Crewalk JA, Defalco A, Foote J, Green B, Juma S, Jung SY, Linsenmeyer TA, MacMillan R, Mayo M, Ozawa H, Roehrborn CG, Shenot PJ, Stone A, Vazquez A, Killorin W, Rivas DA. J Urol; 1999 May; 161(5):1545-50. PubMed ID: 10210393 [Abstract] [Full Text] [Related]
10. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study. Guazzoni G, Montorsi F, Bergamaschi F, Consonni P, Bellinzoni P, Rigatti P. Eur Urol; 1993 May 15; 24(3):332-6. PubMed ID: 7505225 [Abstract] [Full Text] [Related]
11. The UroLume stent in the management of benign prostatic hyperplasia. Milroy E, Chapple CR. J Urol; 1993 Nov 15; 150(5 Pt 2):1630-5. PubMed ID: 7692100 [Abstract] [Full Text] [Related]
12. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. McNicholas TA, Woo HH, Chin PT, Bolton D, Fernández Arjona M, Sievert KD, Schoenthaler M, Wetterauer U, Vrijhof EJ, Gange S, Montorsi F. Eur Urol; 2013 Aug 15; 64(2):292-9. PubMed ID: 23357348 [Abstract] [Full Text] [Related]
13. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. Armitage JN, Cathcart PJ, Rashidian A, De Nigris E, Emberton M, van der Meulen JH. J Urol; 2007 May 15; 177(5):1619-24. PubMed ID: 17437773 [Abstract] [Full Text] [Related]
14. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk]. Serrano-Brambila EA, Camacho-Carvajal JC, Moreno-Aranda J, Martínez-Sánchez R. Gac Med Mex; 2003 May 15; 139(5):435-48. PubMed ID: 14635562 [Abstract] [Full Text] [Related]
15. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. Ghalayini IF, Al-Ghazo MA, Pickard RS. BJU Int; 2005 Jul 15; 96(1):93-7. PubMed ID: 15963128 [Abstract] [Full Text] [Related]
16. Microwave thermotherapy for benign prostatic hyperplasia. Hoffman RM, Monga M, Elliot SP, Macdonald R, Wilt TJ. Cochrane Database Syst Rev; 2007 Oct 17; (4):CD004135. PubMed ID: 17943811 [Abstract] [Full Text] [Related]
17. Outcome of vaportrode transurethral vaporization of the prostate using pressure-flow urodynamic criteria. Desautel MG, Burney TL, Diaz PA, Austria A, Badlani GH. Urology; 1998 Jun 17; 51(6):1013-7. PubMed ID: 9609642 [Abstract] [Full Text] [Related]
18. Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia. Narayan P, Tewari A, Fournier G, Toke A. Urology; 1995 May 17; 45(5):776-82. PubMed ID: 7538239 [Abstract] [Full Text] [Related]
19. The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group. Roehrborn CG, Oesterling JE, Auerbach S, Kaplan SA, Lloyd LK, Milam DE, Padley RJ. Urology; 1996 Feb 17; 47(2):159-68. PubMed ID: 8607227 [Abstract] [Full Text] [Related]
20. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Anjum MI, Chari R, Shetty A, Keen M, Palmer JH. Br J Urol; 1997 Dec 17; 80(6):885-8. PubMed ID: 9439402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]